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Abstract
Background: Bone morphogenetic proteins (BMPs) play important regulatory roles during folliculogenesis. Theca-
derived BMP-4 may be beneficial to in vitro growth culture of early antral follicle-derived oocyte-granulosa cell
complexes (OGCs), which is lacking in theca-derived products.
Methods: BMP-4 (0 [control], 10 and 50 ng/mL) was added to growth culture medium. Growth, steroidogenesis
and the subsequent developmental competence of OGCs derived from bovine early antral follicles (0.5-1 mm) were
examined.
Results: At 4, 8 and 12 days of growth culture, progesterone production by granulosa cells was suppressed by the
addition of BMP-4 compared to the control (P < 0.05). At 12 days, both the OGC survivability and granulosa cell
number in the 50 ng/mL BMP-4 treated group were lower than those of control (48.2 % vs. 67.8 %; 4.96 × 104 vs.
8.5 × 104 cells; P < 0.05, respectively), while no difference was found between 10 ng/mL and the control. The mean
diameters of granulosa cell in the BMP-4 treated groups were smaller than that of the control (P < 0.05). However,
the granulosa cell viability, oocyte diameter, oocyte nuclear maturation rate and normal fertilization rate were
similar in all of the experimental groups, regardless of the amount of BMP-4 addition (P ˃ 0.05). BMP-4 treated
in vitro-grown oocytes showed lower blastocyst rates than untreated ones (P < 0.05).
Conclusions: BMP-4 addition during in vitro growth culture suppressed progesterone production and decreased
the diameter of granulosa cells, suggesting its effect on steroidogenesis; importantly, it did not affect oocyte growth,
nuclear maturation and fertilization. However, BMP-4 impaired subsequent embryonic development, and in higher
concentration (50 ng/mL) even compromised OGC viability by suppressing proliferation of granulosa cells.
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Background
Fully grown oocytes in antral follicles (more than 2 mm
in diameter) are an important source of in vitro embryo
production in cattle [1, 2]. However, the majority of oo-
cytes in an ovary are small oocytes that are either dor-
mant or at various growing stages. It is, therefore,
necessary to utilize these small oocytes to make better
use of ovaries, especially for species for which ovary
samples are extremely rare. Although complete in vitro
development of oocytes from primordial follicles has been
demonstrated in mice [3, 4], it has not been achieved in
other mammals. Among follicles in developmental stages,
early antral follicles show the potential to be a supplemen-
tal source of oocytes because they are most similar in size
to late antral follicles. Several research groups have suc-
cessfully produced live calves from oocytes released from
early antral follicles (less than 1 mm in diameter) after
in vitro growth (IVG), in vitro maturation (IVM), in vitro
fertilization (IVF) and in vitro culture (IVC) [5–7].
Compared to oocytes grown in vivo, however, the
meiotic and developmental competence of IVG oocytes
are generally lower [5, 6, 8]. Therefore, it is necessary to
improve the IVG culture system.
Theca cells are an essential component of growing fol-
licles, supporting follicle growth and development not
only by delivering nutrients and providing the androgens
required for conversion into estrogens by granulosa cells
(GCs) but also by producing growth factors that can
promote follicular development [9]. Bone morphogenetic
proteins (BMPs) are members of the transforming
growth factor-β superfamily of extracellular signaling
molecules, which play multiple roles in the regulation of
the growth, differentiation and apoptosis of numerous
cell types. Theca-derived BMP-4 has been shown to be
capable of regulating the growth and function of GCs by
suppressing apoptosis and enhancing the secretion of
estradiol, while reducing progesterone (P4) secretion
in vitro, an action consistent with a delay of luteinization
and/or atresia [10, 11]. Furthermore, previous in vivo
studies have shown that BMP-4 mRNA was expressed at
high levels in the theca of developing dominant follicles,
while it was very low or undetectable in atretic follicles
[12]. This evidence suggest the possibility that theca-
derived BMP-4 is related to the emergence and/or main-
tenance of dominant follicles; thus, it may contribute to
IVG, which is aimed at producing healthy oocytes similar
to those grown in the dominant follicles. However,
the effects of BMP-4 on oocyte growth and subsequent
developmental competence are unknown because GCs
alone were studies in previous studies [10, 13, 14].
The current IVG protocol for bovine oocytes only uses
theca-free oocyte-granulosa cell complexes (OGCs). As
a result, the products from theca cells, especially growth
factors, such as BMP-4, are absent. Furthermore, a
previous study showed P4 concentration (68 ng/ml) in
the follicular fluid of the growing antral follicles with a
low antral follicle count (AFC) were double that in folli-
cles with a high AFC (32 ng/ml) [15]. It was also re-
ported that oocytes derived from follicles with a low
AFC had a much lower blastocyst formation rate [15]. A
low AFC is associated with diminished ovarian function
and fertility in both human and cow [16, 17]. Our pre-
liminary study found P4 concentration in the IVG cul-
ture medium soared above 60 ng/ml, a high level
comparable to that in follicles with a low AFC. There-
fore, in an attempt to compensate for the missing roles
of theca cells and reduce P4 production during IVG cul-
ture, the aim of our study was clarifying the functions of
BMP-4 produced by theca cells. We asked whether
BMP-4 adding in the IVG culture medium affects OGC
growth, P4 production and subsequent developmental
competence acquisition in the present study.
Methods
Collection of OGCs and IVG culture
Bovine ovaries obtained from a slaughterhouse were kept
in plastic bags at 20 °C and were transported to the la-
boratory within 6 to 10 h after collection. After three
washes in saline, sliced ovarian cortex strips (<1 mm
thick) were prepared using a surgical blade (No. 11). Early
antral follicles (0.5-1 mm in diameter) were dissected from
cortex strips using a surgical blade (No. 20) under a
stereomicroscope in TCM199 (Invitrogen; Grand Island,
NY, USA) supplemented with 0.1 % polyvinyl alcohol,
25 mM HEPES, 10 mM sodium bicarbonate, and 50 μg/
mL gentamicin sulfate (isolation medium, pH 7.4), as de-
scribed elsewhere [18]. Follicles were punctured to release
OGCs using a pair of fine forceps, and the OGCs with a
normal appearance were individually cultured for 12 days
in 96-well culture plates (Becton, Dickinson and Co.,
Franklin Lakes, NJ, USA) with 200 μL of growth medium
at 39 °C in humidified air with 5 % CO2. The growth
medium was HEPES-buffered TCM199 supplemented
with 0.91 mM sodium pyruvate, 1 μg/mL estradiol-
17β, 5 % fetal calf serum (FCS; Invitrogen), 4 mM
hypoxanthine, 4 % polyvinylpyrrolidone (MW 360,000)
and 50 μg/mL gentamicin sulfate. Half of the medium was
replaced every 4 days, throughout the culture, 10 and
50 ng/ml BMP-4 (HumanZyme, Inc., Chicago, IL, USA)
was added to IVG medium while 0 ng/ml BMP-4 group
worked as non-treated control. The doses of BMP-4 were
selected based on previous in vitro studies, in which
BMP-4 at these doses was demonstrated to be effective in
suppressing GC apoptosis and P4 production [10, 14].
P4 assay
The culture medium collected at 4, 8 and 12 days of
IVG culture was frozen at −30 °C until P4 assay by using
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enzyme immunoassay, as previously described [19]. IVG
media were loaded directly as a sample to the well of a
microplate. Anti-progesterone-3CMO-BSA (KZ-HS-P13,
Cosmo Bio Co., Ltd., Tokyo, Japan) was used as the pri-
mary antibody, and goat anti-rabbit serum (111-005-003,
Jackson Immuno Research Laboratories, Inc., PA, USA)
was used as the secondary antibody. The intra- and
inter-assay coefficients of variations were 5.8 % and
9.8 %, respectively.
Evaluation of OGC growth
In the present study, the viability of OGC, as well as the
diameter, viability and number of GCs, were considered
as OGC growth parameters. Before and after IVG cul-
ture, OGC growth parameters were measured. The sur-
vivability of OGCs was evaluated by their morphological
appearance; oocytes completely enclosed by several
healthy granulosa cell layers were considered to be viable
[18]. The diameter, viability and number of GCs from
viable OGCs were assessed using an acridine orange/
propidium iodide cell viability kit together with a cell
counter (F23001 and L2000, respectively; Logos Biosys-
tems, Gyunggi, Republic of Korea). To prepare disper-
sive GCs for the counting, culture medium in the well of
each viable OGC was removed and replaced with 100 μL
of D-PBS (−) supplemented with 0.125 % trypsin and
0.05 % EDTA. After 10 min of trypsinization and pipet-
ting several times, 25 μL of FCS was added to stop the
digestion, and then, the denuded oocyte was removed
from the well and discarded.
IVM of in vivo-grown and IVG oocytes
In vivo-derived oocytes, serving as control, were collected
from antral follicles (2–8 mm diameter) and submitted to
IVM as described previously [20]. Briefly, cumulus-oocyte
complexes (COCs) were incubated in droplets of IVM
medium (approximately 10 COCs/50 μL) and were then
covered with paraffin oil for 22 h at 39 °C in a humidified
atmosphere with 5 % CO2. The maturation medium con-
sisted of HEPES-buffered TCM199 supplemented with
0.2 mM sodium pyruvate, 0.02 units/mL FSH (from por-
cine pituitary), 1 μg/mL estradiol-17β, 10 % FCS, and
50 mg/mL gentamicin sulfate.
For IVG oocytes, COCs were isolated from the viable
OGCs for pre-IVM and IVM as previously described [7].
Briefly, oocytes were individually cultured in individual
wells of micro-well plates (MiniTrays 163118; NUNC,
Roskilde, Denmark) that contained 6 mL of pre-IVM
medium, and then, 6 mL of IVM medium for 10 and
22 h at 39 °C in a humidified atmosphere with 5 % CO2
[21]. Pre-IVM medium, which is modified from IVM
medium, contained additional 0.5 mM 3-isobutyl-1-
methylxanthine, a phosphodiesterase inhibitor, and a
lower FSH concentration (2 × 10−6 units/mL) [7].
Before IVG and after IVM culture, all 92 oocytes
were measured for their diameters as previously de-
scribed [18]. Briefly, the diameter of each denuded
oocyte was measured using an inverted microscope
(CK40, Olympus, Tokyo, Japan) connected to a CCD
camera (Moticam 2000, Shimadzu Rika Corporation,
Tokyo, Japan) and image processing software (Motic
Images Plus 2.2 s, Shimadzu).
IVF and IVC
IVF was performed according to a previously described
procedure [22]. Briefly, COCs were co-incubated with
frozen-thawed motile sperm (5 × 106 sperm/mL) sepa-
rated by a Percoll gradient (45 % and 90 %). Approxi-
mately 10 COCs were cultured in a 100-μL droplet of
modified Brackett and Oliphant isotonic medium con-
taining 3 mg/mL fatty acid–free BSA and 2.5 mM theo-
phylline for 18 h at 39 °C in a humidified atmosphere
with 5 % CO2, 5 % O2 and 90 % N2.
Only 10 ng/mL BMP-4 treatment were investigated
for IVC because a low survival rate in 50 ng/mL BMP-4
treated OGCs was observed during IVG. IVC was per-
formed as previously described [20]. Briefly, presumptive
zygotes were denuded by vortexing and washed three
times in culture medium. Then approximately 30 zy-
gotes were cultured in a 30-μL droplet of culture
medium for 6 days at 39 °C in a humidified atmosphere
with 5 % CO2, 5 % O2 and 90 % N2. The culture medium
consisted of modified synthetic oviduct fluid containing
1 mM glutamine, twelve essential amino acids for basal
medium Eagle, seven nonessential amino acids for mini-
mum essential medium, 10 μg/mL insulin, and 5 mM
glycine, 5 mM taurine, 1 mM glucose, and 3 mg/mL
fatty acid-free BSA.
Evaluation of oocyte nuclear maturation and fertilization
Following IVM or IVF, oocytes were denuded from
cumulus cells by vortexing and were then stained
with 1 % aceto-orcein. To evaluate nuclear matur-
ation, the nuclear status was classified as germinal
vesicle (GV), metaphase I (MI), anaphase I/telophase
I (AI/TI), and metaphase II (MII) by observation
under a phase-contrast microscope. The diameter of
each denuded oocyte after IVM (before fixation) was
measured and was considered the oocyte diameter
after IVG culture. To evaluate fertilization, the oo-
cytes were considered to be penetrated by sperm
when they had one or more enlarged sperm head (s)
or male pronucleus (ei) with corresponding sperm tail
(s). Monospermic penetration was defined as normal
fertilization in which oocytes have a single male pro-
nucleus and a female pronucleus, or a single enlarged
sperm head with the chromosomes at AII/TII. Cleav-
age and the blastocyst rates were determined after
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2 days and 6 days of IVC, respectively, and the cell
numbers in blastocysts were counted using an air-
drying method [23].
Statistical analysis
All statistical analyses were performed using JMP soft-
ware version 11.0.0 (SAS Institute, Cary, NC, USA). The
effects of the BMP-4 treatments on the GC diameter,
viability and number, oocyte diameter and blastocyst cell
number were analyzed by one-way ANOVA followed by
Turkey-Kramer’s HSD as a post hoc test. The effects of
the BMP-4 treatments and culture duration on the P4
concentration were analyzed by two-way ANOVA
followed by Turkey-Kramer’s HSD as a post hoc test.
The effect of the BMP-4 treatments on the OGC viabil-
ity, oocyte nuclear maturation and fertilization, and
blastocyst rate were analyzed by a chi-square test.
Results
Growth of OGC
Table 1 shows the OGC growth parameters before and
after IVG culture with or without BMP-4 treatments.
After 12 days of IVG culture, 50 ng/mL BMP-4 treated
OGCs showed lower viability (48.2 %, P < 0.05) com-
pared to others (~70 %). The viability, diameter and
number of GCs significantly increased (P < 0.05) com-
pared to those of the pre-IVG culture. The GC viabilities
in all of the experimental groups were similar; however,
the GC number in the 50 ng/mL BMP-4 treated group
was lower than that of the control group (P < 0.05). In
both BMP-4 treatments, a smaller mean diameter of
GCs (11.2 and 11.0 μm) was observed compared to that
of the controls (12.0 μm) (P < 0.05).
P4 production of OGC
As shown in Fig. 1, the P4 concentration in the culture
medium of the control group increased throughout the
duration of IVG culture (P < 0.05). However, in the
BMP-4 treated groups, the P4 concentration was de-
creased on day 8 and 12 of IVG culture in comparison
to control (P < 0.05). There was no difference in P4 pro-
duction between BMP-4 treated groups.
Subsequent developmental competence
As shown in Tables 2 and 3, the oocyte diameter, nuclear
maturation and fertilization were not significantly af-
fected by the BMP-4 treatments, although there was a
decreasing tendency of total penetration in the 50 ng/
mL BMP-4 treated group. IVG oocytes, regardless of
BMP-4 addition, were smaller and had lower rates of
normal fertilization and total penetration than in vitro-
grown oocytes (P < 0.05). As shown in Table 4, the cleav-
age rates after IVF were similar between BMP-4 treated
and non-treated IVG oocytes; however, BMP-4 treated
oocytes had lower blastocyst rates, based on both insem-
inated oocytes and cleaved oocytes (P < 0.05). Compared
to the in vivo-grown oocytes, IVG oocytes showed lower
cleavage and blastocyst rates (P < 0.05).
Discussion
In the current study, BMP-4 suppressed P4 production
from GCs, in agreement with the results of other in vitro
studies [13, 14]. It has been reported that the inhibition
of the acetylation of histone H3 associated with the ste-
roidogenic acute regulatory protein promoter region by
BMP-4 may be one of the underlying molecular mecha-
nisms of the inhibition of P4 synthesis in GCs [13].
Because increased P4 synthesis is a characteristic of the
GC luteinization process [24], BMP-4 showed an effect
of anti-luteinization. This effect was further verified by
the significantly smaller diameter (~11 μm) of GCs in
the BMP-4 treated groups after IVG culture compared
to non-BMP-4 treated control (12.0 μm). It has been re-
ported that both in vivo-grown large luteal cells origi-
nated from GCs and in vitro-luteinized GCs have similar
sizes, which are larger than that of GCs in pre-ovulatory
follicles (mean diameter, 38.4 vs.10.6 μm, respectively)
[25, 26]. Therefore, the delay in GC enlargement ob-
served in the present study may be attributed to delayed
luteinization, which is associated with reduced P4 syn-
thesis in GCs treated with BMP-4. It is known that GCs
become luteinized and P4 secretion from GCs increases
in atretic follicles [27, 28]. In the present study, however,
BMP-4 treatment reduced P4 to a level (~33 ng/ml)
close to that of follicular fluid (~32 ng/ml) in growing
antral follicles with high AFC [17]. These data indicate








Counting (× 103 cells) % of viability (n) Diameter (μm)
0 - 100.0a (30) 2.0 ± 0.5c 88.7 ± 2.8b (30) 9.3 ± 1.1c
12 0 67.8b (242) 85.0 ± 33.7a 92.8 ± 3.4a (26) 12.0 ± 0.8a
10 70.4b (250) 69.0 ± 23.5ab 93.2 ± 2.9a (25) 11.2 ± 0.9b
50 48.2c (247) 49.6 ± 12.4b 93.7 ± 3.2a (14) 11.0 ± 0.9b
Data are presented as the mean ± standard deviation
abcValues with different superscripts in the same column are significantly different (p < 0.05)
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the possibility for developing an in vitro model mimick-
ing the growth of bovine oocytes in healthy follicles.
Despite the similarity in the ability to delay luteinization,
the 50 ng/mL BMP-4 treatment caused a decrease in the
GC number relative to the controls, while 10 ng/mL
BMP-4 did not. It appears that BMP-4 impaired prolifera-
tion, but did not induce apoptosis of GCs, as the viability
of GCs was high (more than 90 %) in all of the experimen-
tal groups. This finding is inconsistent with previous stud-
ies in which 50 or 100 ng/mL BMP-4 did not affect GC
proliferation over 6 or 4 days of GC culture, respectively
[13, 14]. We didn’t expected the GC number to decrease
with BMP-4 treatment because it has been demonstrated
that BMP-4 could reduce apoptosis of GCs by suppressing
the action of caspase-activated DNase induced by
Survivin, a member of the inhibitor of apoptosis fam-
ily [10]. One major difference between the present
and the previous studies is that we cultured OGCs,
rather than GCs alone. The involvement of oocytes
complicates the culture system and may be respon-
sible for the discrepancies. It is now widely recog-
nized that oocyte secreted factors (OSFs), such as
growth differentiation factor-9 (GDF-9) and BMP-15,
direct the functions of their surrounding GCs, includ-
ing the promotion of cell growth and prevention of
cell death and luteinization [29–32]. Because the
types of receptors for the transforming growth factor-
β superfamily are limited, ligands of the BMP/GDF
subfamily bind to receptors in a shared manner [33].
Among the limited receptors, BMP type-II receptor is the
sole type-II receptor presenting in GCs for GDF-9 and
BMP-15 and is also an important receptor for BMP-4
[34]. In follicles, GDF-9 and BMP-4 could induce GCs to
produce Gremlin, which is known to be effective at
antagonizing BMP-4 actions without affecting oocyte-
derived GDF-9 and BMP-15 [31, 35, 36]. As a result, it is
proposed that oocyte could maintain its surrounding
microenvironment, which is important for oocyte devel-
opment, from the actions of theca-derived BMPs [31].
Take into consideration of the fact that a 20-fold excess of
gremlin to BMP-4 was needed to completely block BMP-4
action [35], exogenous BMP-4 at the doses studied (10
and 50 ng/ml) may be too high and probably impaired the
function of OSFs by competitively binding receptors
Fig. 1 Effect of BMP-4 on progesterone (P4) production by GCs during IVG culture.
abcDifferent letters represent differences among the same
doses of BMP-4 (P < 0.05). xyDifferent letters represent differences within same day of culture (P < 0.05). Bars represent the standard deviation






Mean oocyte diameter (μm) % of nuclear status (no.)
Before IVG After IVM M I A I/ T I M II
In vitro grown 0 33c (4) 98.9 ± 3.4 116.9 ± 4.1b 6.5 (2) 0 93.5 (29)
10 29 (4) 99.4 ± 3.0 117.7 ± 3.5b 10.3 (3) 0 89.7 (26)
50 30 (4) 99.1 ± 3.1 116.8 ± 2.9b 3.3 (1) 3.3 (1) 93.4 (28)
In vivo grownd - 32 (3) - 120.2 ± 3.1a 6.3 (2) 0 93.8 (30)
Abbreviations: M I metaphase I, A I/T I anaphase I/telophase I, M II metaphase II
abValues with different superscripts in the same column are significantly different (p < 0.05)
cFor the evaluation of nuclear maturation, 31 oocytes in the 0 ng/ml BMP-4 treated group were used because 2 oocytes were lost during fixation
dOocytes collected from antral follicles (2–8 mm in diameter) served as in vivo-derived controls
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against OSFs, resulting in decreased GC proliferation in a
dose-dependent manner. A smaller number of GCs in the
50 ng/mL BMP-4 treated group, in turn, may lead to the
decreased OGC viability when consider the fact that oo-
cytes also relay on the support of GCs for long-term
growth.
In the present study, BMP-4 treatment did not pro-
mote oocyte growth. However, BMP-7, another theca-
derived growth factor, increased the oocyte diameter and
volume during IVG, in which OGCs were cultured in
groups on membrane inserts [37]. The culture system
may partially cause the different results, but unknown
differences in the biological function between BMP-4
and–7 may also be responsible [34]. Our study showed
that BMP-4 impaired embryo development of IVG oo-
cytes without affecting oocyte nuclear maturation and
fertilization, indicating that BMP-4 may inhibit the cyto-
plasmic maturation of oocytes. Another study reported
that BMP-4 addition during IVM of COC had no effect
on bovine oocyte nuclear maturation and subsequent
embryo development [38]. The differences in the growth
stage of oocytes and exposure time to BMP-4 may have
led to the discrepancy. Through OSFs, oocytes appear to
control their neighboring somatic cells, directing them
to perform functions required for the appropriate devel-
opment of oocytes. The presence of this regulatory loop
was demonstrated by the fact that the neutralization of
OSFs by antagonists of BMP-15 and GDF-9 during IVM
impaired the developmental competence of COCs [39].
Although there was no BMP-4 addition during pre-IVM
and IVM in the present study, the presumed interrup-
tion of the regulatory loop by BMP-4 during IVG ap-
peared to cause a lasting adverse effect, as shown in the
subsequent developmental competence of oocytes. Fur-
ther investigations are necessary to verify this type of
receptor competition between BMP-4 and OSFs and its
consequential effects.
Compared to in vivo-grown oocytes, IVG oocytes
showed inferior competences for fertilization and de-
velopment to blastocyst, although their nuclear mat-
uration was similar to in vivo-grown ones, indicating
that the cytoplasmic maturation of IVG oocytes might
be inadequate.
To our knowledge, this is the first study utilizing
OGCs model to investigate the BMPs on growth, ste-
roidogenesis and subsequent developmental competence
of OGCs derived from bovine early antral follicles. This
model will be helpful for studying the function of BMPs
or other growth factors in growing antral follicles in a
more comprehensive way.
Conclusions
BMP-4 addition during IVG culture suppressed P4 pro-
duction from GCs and decreased the diameter of GC,
suggesting its effect on steroidogenesis; importantly, it
did not affect oocyte growth, nuclear maturation and
fertilization. However, BMP-4 impaired embryonic de-
velopment maybe due to insufficient cytoplasmic matur-
ation and in higher concentration (50 ng/mL) even
compromised OGC viability by suppressing GC prolifer-
ation. In future studies, we should investigate the cyto-
plasmic maturation of IVG oocytes treated with BMP-4;
moreover, we should develop the IVG system for the
production of oocytes with high developmental compe-
tence without GC luteinization.









In vitro grown 0 73 (9) 16.4 43.8b 60.2b 6.8 67.0b
10 91 (9) 13.2 48.4b 61.6b 9.9 71.5b
50 53 (9) 5.7 41.5b 47.2b 7.5 54.7b
In vivo grownc - 83 (3) 6.0 80.7a 86.7a 7.2 93.9a
Abbreviations: ESH enlarged sperm head, 2PN two pronuclei
abValues with different superscripts in the same column are significantly different (p < 0.05)
cOocytes collected from antral follicles (2–8 mm in diameter) served as in vivo-derived controls







% of blastocysts based on Cell no. in
blastocysts (n)Inseminated oocytes Cleaved oocytes
In vitro grown 0 257 (8) 54.9b 9.3b 17.0b 91.4 ± 13.1b (24)
10 239 (7) 47.3b 1.3c 2.7c 142.0 ± 45.6d (2)
In vivo growne - 150 (5) 76.7a 25.3a 33.0a 164.6 ± 10.4a (19)
abcValues with different superscripts in the same column are significantly different (p < 0.05)
dOne blastocyst was lost during cell counting; as a result, no statistical comparison was conducted
eOocytes collected from antral follicles (2–8 mm in diameter) served as in vivo-derived controls
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Abbreviations
2PN: Two pronuclei; AFC: Antral follicle count; AI/TI: Anaphase I/telophase I;
ANOVA: analysis of variance; BMPs: Bone morphogenetic proteins;
COC: Cumulus-oocyte complex; DNase: Deoxyribonuclease; D-PBS: Dulbecco’s
phosphate buffered saline; EDTA: Ethylenediaminetetraacetic acid;
ESH: Enlarged sperm head; FCS: Fetal calf serum; FSH: Follicle-stimulating
hormone; GC: Granulosa cell; GDF: Growth differentiation factor; GV: Germinal
vesicle; HEPES: 2-[4-(2-Hydroxyethyl)-1-piperazinyl] ethanesulfonic Acid;
HSD: Honestly significant difference; IVC: in vitro culture; IVF: in vitro fertilization;
IVG: in vitro growth; IVM: in vitro maturation; MI: metaphase I; MII: metaphase II;
mRNA: messenger RNA; OGC: oocyte-granulosa cell complex; OSF: oocyte
secreted factor; P4: progesterone; TCM199: tissue culture medium 199.
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